TRACON PHARMACEUTICALS, INC ANNOUNCES PRESENTATION AT RODMAN and RENSHAW 8TH ANNUAL HEALTHCARE CONFERENCE
Released on = November 3, 2006, 10:18 am
Press Release Author = TRACON Pharmaceuticals, Inc.
Industry = Biotech
Press Release Summary = San Diego, CA (November 3, 2006) - TRACON Pharmaceuticals, Inc. announced today that it will present at the Rodman & Renshaw 8th Annual Healthcare Conference on Monday, November 6, 2006 at 4:35 p.m. Eastern Time.
Press Release Body = San Diego, CA (November 3, 2006) - TRACON Pharmaceuticals, Inc. announced today that it will present at the Rodman & Renshaw 8th Annual Healthcare Conference on Monday, November 6, 2006 at 4:35 p.m. Eastern Time.
Charles P. Theuer, M.D., Ph.D., President and Chief Executive Officer of TRACON, will provide an overview of the Company and its programs. The presentation is scheduled to be broadcast live on Monday, November 6, 2006 at 4:35 p.m. Eastern Time. The session may be accessed through the Company's website www.traconpharma.com under the Company News section or by going directly to http://www.wsw.com/webcast/rrshq10/tracon/ at the time of the presentation. An archived version of the presentation will be available after the live webcast through February 4, 2007. About TRACON Pharmaceuticals, Inc.
TRACON Pharmaceuticals, Inc. is a fast growing biotechnology company developing next-generation targeted therapies for cancer and related diseases. We are addressing unmet needs in this arena with product candidates that focus on cellular targets specifically implicated in cancer growth and angiogenesis. We believe that these treatments will offer benefits far exceeding those provided by cytotoxic treatments and first generation targeted therapies. By developing and commercializing novel products in underserved indications with improved results, TRACON will maximize patient benefits and enhance shareholder value. For more information, visit the company's website at: www.traconpharma.com Contact: TRACON Pharmaceuticals, Inc. Delia Valdovinos, 858-550-0780 ext 232 dvaldovinos@traconpharma.com
2022
